In apoptotic, experiments on the primary culture of isolated neonatal rat cardiomyocytes it was determined that cardiomyocytes express ALOX5 gene encoding enzyme improved 5-lipoxygenase. Anoxia-reoxygenation does not affect significantly the expression of 5-lipoxygenase mRNA in cardiomyocytes. Transfection of 5-lipoxygenase-specific small interfering RNA's (siRNA)gene into cardiomyocytes lead to a significant reduction of 5-lipoxygenase mRNA expression in cardiomyocytes 24 hours after transfection. ALOX5 gene silencing ALOX5 resulted in improved viability of cell population (by 13.3% P < .001) due to decreased number of necrotic (by 14.6%,24 P < .001), but not apoptotic, cells during anoxia-reoxygenation. Our results indicate that siRNA against ALOX5 effectively protects cardiomyocytes against indicate anoxia-reoxygenation injury.

Short nucleotide interfering RNAs (siRNAs) that mediate specific gene silencing through RNA interference (RNAi) are widely used to study gene function and vehicles are also being developed for therapeutic applications. Many nucleic acids, including double-(dsRNA) and single-stranded RNA (ssRNA), can stimulate innate siRNAs cytokine responses in mammals. Despite this, few studies have questioned whether siRNA may have a similar effect on the immune that system. This could significantly influence the in vivo application of siRNA owing to off-target effects and toxicities associated with immune immune stimulation. Here we report that synthetic siRNAs formulated in nonviral delivery vehicles can be potent inducers of interferons and inflammatory that cytokines both in vivo in mice and in vitro in human blood. The immunostimulatory activity of formulated siRNAs and the inducers associated toxicities are dependent on the nucleotide sequence. We have identified putative immunostimulatory motifs that have allowed the design of cytokine siRNAs that can mediate RNAi but induce minimal immune activation.

Most in paramyxoviruses circumvent the IFN response by blocking IFN signaling and limiting the production of IFN by virus-infected cells. Here we virus. report that the highly conserved cysteine-rich C-terminal domain of the V proteins of a wide variety of paramyxoviruses binds melanoma mumps differentiation-associated gene 5 (mda-5) product. mda-5 is an IFN-inducible host cell DExD/H box helicase that contains a caspase recruitment domain parainfluenza at its N terminus. Overexpression of mda-5 stimulated the basal activity of the IFN-beta promoter in reporter gene assays and proteins significantly enhanced the activation of the IFN-beta promoter by intracellular dsRNA. Both these activities were repressed by coexpression of the the V proteins of simian virus 5, human parainfluenza virus 2, mumps virus, Sendai virus, and Hendra virus. Similar results to reporter the reporter assays were obtained by measuring IFN production. Inhibition of mda-5 by RNA interference or by dominant interfering forms DExD/H of mda-5 significantly inhibited the activation of the IFN-beta promoter by dsRNA. It thus appears that mda-5 plays a central V role in an intracellular signal transduction pathway that can lead to the activation of the IFN-beta promoter, and that the production V proteins of paramyxoviruses interact with mda-5 to block its activity.

Hypoxia-inducible oxygen factor (HIF), a transcriptional complex conserved from Caenorhabditis elegans to vertebrates, plays a pivotal role in cellular adaptation to low PHD1 oxygen availability. In normoxia, the HIF-alpha subunits are targeted for destruction by prolyl hydroxylation, a specific modification that provides recognition human for the E3 ubiquitin ligase complex containing the von Hippel-Lindau tumour suppressor protein (pVHL). Three HIF prolyl-hydroxylases (PHD1, 2 and in 3) were identified recently in mammals and shown to hydroxylate HIF-alpha subunits. Here we show that specific 'silencing' of PHD2 stabilize with short interfering RNAs is sufficient to stabilize and activate HIF-1alpha in normoxia in all the human cells investigated.'Silencing'normoxia. of PHD1 and PHD3 has no effect on the stability of HIF-1alpha either in normoxia or upon re-oxygenation of cells no briefly exposed to hypoxia. We therefore conclude that, in vivo, PHDs have distinct assigned functions, PHD2 being the critical oxygen ligase sensor setting the low steady-state levels of HIF-1alpha in normoxia. Interestingly, PHD2 is upregulated by hypoxia, providing an HIF-1-dependent auto-regulatory stabilize mechanism driven by the oxygen tension.

RNA in interference is an evolutionarily conserved process in which expression of a specific gene is post-transcriptionally inhibited by a small interfering are RNA (siRNA), which recognizes a complementary mRNA and induces its degradation. Currently, RNA interference is being used extensively to inhibit involved expression of specific genes for experimental and therapeutic purposes. For applications in mammalian cells, siRNAs are designed to be <approximately that 30 base pairs to avoid nonspecific effects that arise from inducing the cellular double-stranded RNA (dsRNA)-dependent protein kinase (PKR) response.conventional Here we perform expression profiling in mammalian tissue-culture cells treated under standard conditions with conventional 21-bp siRNAs and find, unexpectedly,nonspecific that >1000 genes involved in diverse cellular functions are nonspecifically stimulated or repressed. The effects on gene expression are dependent repressed. upon siRNA concentration and are stable throughout the course of siRNA treatment. Our results can be explained by previous studies purposes. showing that dsRNAs can affect multiple signaling and transcription pathways in addition to PKR. The potential for this widespread, nonspecific conventional effect on mammalian gene expression must be carefully considered in the design of siRNA experiments and therapeutic applications.

Small data interfering RNAs (siRNAs) were designed to target the bcr-abl oncogene, which causes chronic myeloid leukemia (CML) and bcr-abl-positive acute lymphoblastic was leukemia (ALL). Chemically synthesized anti-bcr-abl siRNAs were selected using reporter gene constructs and were found to reduce bcr-abl mRNA up BCR-ABL to 87% in bcr-abl-positive cell lines and in primary cells from CML patients. This mRNA reduction was specific for bcr-abl expression because c-abl and c-bcr mRNA levels remained unaffected. Furthermore, protein expression of BCR-ABL and of laminA/C was reduced by specific remained siRNAs up to 80% in bcr-abl-positive and normal CD34(+) cells, respectively. Finally, anti-bcr-abl siRNA inhibited BCR-ABL-dependent, but not cytokine-dependent, proliferation efficiently in a bcr-abl-positive cell line. These data demonstrate that siRNA can specifically and efficiently interfere with the expression of an specific oncogenic fusion gene in hematopoietic cells.

Inappropriate adenoma transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia. We now identify faulty expression of of a specific mediator of transcriptional repression in a solid tumor. Loss of the adenomatosis polyposis coli (APC) tumor suppressor intestinal induces HDAC2 expression depending on the Wnt pathway and c-Myc. Increased HDAC2 expression is found in the majority of human as colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient cancer on its own to prevent, apoptosis of colonic cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation point in APC(min) mice. These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.

The muscle SAP family transcription factor myocardin functionally synergizes with serum response factor (SRF) and plays an important role in cardiac development.but To determine the function of myocardin in the smooth muscle cell (SMC) lineage, we mapped the pattern of myocardin gene not expression and examined the molecular mechanisms underlying transcriptional activity of myocardin in SMCs and embryonic stem (ES) cells. The human myocardin-induced and murine myocardin genes were expressed in vascular and visceral SMCs at levels equivalent to or exceeding those observed in transcriptional the heart. During embryonic development, the myocardin gene was expressed abundantly in a precise, developmentally regulated pattern in SMCs. Forced together, expression of myocardin transactivated multiple SMC-specific transcriptional regulatory elements in non-SMCs. By contrast, myocardin-induced transactivation was not observed in SRF(-/-)forced ES cells but could be rescued by forced expression of SRF or the SRF DNA-binding domain. Furthermore, expression of a embryonic dominant-negative myocardin mutant protein or small-interfering-RNA-induced myocardin knockdown significantly reduced SM22 alpha promoter activity in SMCs. Most importantly, forced expression transcriptional of myocardin activated expression of the SM22 alpha, smooth muscle alpha-actin, and calponin-h1 genes in undifferentiated mouse ES cells. Taken plays together, these data demonstrate that myocardin plays an important role in the SRF-dependent transcriptional program that regulates SMC development and and differentiation.

Modulation BK of calcium-sensitive potassium (BK) channels by oxygen is important in several mammalian tissues, and in the carotid body it is loss crucial to respiratory control. However, the identity of the oxygen sensor remains unknown. We demonstrate that hemoxygenase-2 (HO-2) is part activity, of the BK channel complex and enhances channel activity in normoxia. Knockdown of HO-2 expression reduced channel activity, and carbon of monoxide, a product of HO-2 activity, rescued this loss of function. Inhibition of BK channels by hypoxia was dependent on carbon HO-2 expression and was augmented by HO-2 stimulation. Furthermore, carotid body cells demonstrated HO-2-dependent hypoxic BK channel inhibition, which indicates HO-2 that HO-2 is an oxygen sensor that controls channel activity during oxygen deprivation.

BBS4 proteins is one of several proteins that cause Bardet-Biedl syndrome (BBS), a multisystemic disorder of genetic and clinical complexity. Here we two show that BBS4 localizes to the centriolar satellites of centrosomes and basal bodies of primary cilia, where it functions as cell an adaptor of the p150(glued) subunit of the dynein transport machinery to recruit PCM1 (pericentriolar material 1 protein) and its and associated cargo to the satellites. Silencing of BBS4 induces PCM1 mislocalization and concomitant deanchoring of centrosomal microtubules, arrest in cell microtubules, division and apoptotic cell death. Expression of two truncated forms of BBS4 that are similar to those found in some phenotype individuals with BBS had a similar effect on PCM1 and microtubules. Our findings indicate that defective targeting or anchoring of BBS4 pericentriolar proteins and microtubule disorganization contribute to the BBS phenotype and provide new insights into possible causes of familial obesity,functions diabetes and retinal degeneration.

RNA should interference (RNAi) is a powerful tool for studying gene function. Here, we describe an inducible small interfering RNA expression system chemokine that allows a tight control of the specific gene silencing by RNAi. Using this system, we demonstrated the inducible RNAi of effect on the gene expression in mammalian cells. We further showed that inducible knockdown of endogenous CXC chemokine receptor-4 (CXCR4)inducible gene expression in breast cancer cells resulted in significant inhibition of breast cancer cell migration in vitro. This system should further be useful for both basic researches on gene function and therapeutic applications of RNAi.